Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Madrigal Pharmaceuticals, Inc.”

25 pharma patents match "Madrigal Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 25
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 25 pharmaceutical patents matching "Madrigal Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

25 results for “Madrigal Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12377104

    Methods for treating a fatty liver disease

    Madrigal Pharmaceuticals, Inc. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted

  2. US 11986481

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted

  3. US 11806353

    Methods of treating liver disorders or lipid disorders with a THR-beta agonist

    Madrigal Pharmaceuticals, Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  4. US 11564926

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted

  5. US 11491145

    Combination therapies comprising targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted

  6. US 11377447

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  7. US 11090308

    Methods of treating liver disorders or lipid disorders with a THR-beta agonist

    Madrigal Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

  8. US 10894050

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  9. US 10828315

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  10. US 10722525

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  11. US 10675360

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  12. US 10376517

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  13. US 10376598

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  14. US 10232049

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  15. US 10117944

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  16. US 9968612

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted May 15, 2018 · Expires May 10, 2038

    granted

  17. US 9956293

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  18. US 9910031

    Compositions and methods for modulating c-Rel-dependent cytokine production

    Madrigal Pharmaceuticals, Inc. · Granted Mar 6, 2018 · Expires Mar 1, 2038

    granted

  19. US 9266861

    Method of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  20. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  21. US 8211914

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  22. US 8211884

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  23. US 8153644

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  24. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.